Daclizumab [clinicaltrials_resource:433023f88e21dc203cf5b59479835caa]
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac [clinicaltrials:NCT00001249]ANTI-TAC THERAPY FOR UVEITIS [clinicaltrials:NCT00001526]clinicaltrials:NCT00001575Zenapax to Treat Multiple Sclerosis [clinicaltrials:NCT00001934]clinicaltrials:NCT00001941clinicaltrials:NCT00001962Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006350]clinicaltrials:NCT00014911Monoclonal Antibody Therapy in Treating Patients With Leukemia [clinicaltrials:NCT00019227]Pediatric Kidney Transplant Without Calcineurin Inhibitors [clinicaltrials:NCT00023231]Study of Daclizumab in Patients With Chronic, Persistent Asthma [clinicaltrials:NCT00028288]Daclizumab to Treat Wegener's Granulomatosis [clinicaltrials:NCT00040248]Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis [clinicaltrials:NCT00043667]Daclizumab to Treat Chronic Immune Thrombocytopenia [clinicaltrials:NCT00049725]To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris [clinicaltrials:NCT00050648]clinicaltrials:NCT00050661Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease [clinicaltrials:NCT00053976]clinicaltrials:NCT00064714Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis [clinicaltrials:NCT00070759]Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis [clinicaltrials:NCT00071838]A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) [clinicaltrials:NCT00072969]Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis [clinicaltrials:NCT00073047]Daclizumab and Sirolimus to Treat Uveitis [clinicaltrials:NCT00078689]Daclizumab to Treat HIV-Infected Patients [clinicaltrials:NCT00080431]clinicaltrials:NCT00100178Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis [clinicaltrials:NCT00109161]clinicaltrials:NCT00130637clinicaltrials:NCT00141037The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation [clinicaltrials:NCT00181142]clinicaltrials:NCT00195273MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients [clinicaltrials:NCT00231764]clinicaltrials:NCT00246129Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients [clinicaltrials:NCT00284531]clinicaltrials:NCT00296348clinicaltrials:NCT00304954Combination Daclizumab/Denileukin Diftitox to Treat Uveitis [clinicaltrials:NCT00326508]A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients [clinicaltrials:NCT00363116]clinicaltrials:NCT00390221clinicaltrials:NCT00446264clinicaltrials:NCT00468117
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Daclizumab [clinicaltrials_resource:433023f88e21dc203cf5b59479835caa]
Bio2RDF identifier
433023f88e21dc203cf5b59479835caa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:433023f88e21dc203cf5b59479835caa
identifier
clinicaltrials_resource:433023f88e21dc203cf5b59479835caa
title
Daclizumab
@en
type
label
Daclizumab [clinicaltrials_resource:433023f88e21dc203cf5b59479835caa]
@en